Aifa: in September the Board of Directors approves 9 new drugs, three of which are anti-tumor drugs [Google translation]

Jaypirca (pirtobrutinib) - Eli Lilly

Tafinlar (dabrafenib) - Novartis

Epkinly (epcoritamab-bysp) - Genmab, AbbVie

Erwinase (erwinia L-asparaginase) - Jazz, Ohara Pharma

Mekinist (trametinib) - Novartis, BeiGene

Sep 12, 2024